| Financial Year |
March 31 2023 |
| Monetary Funds |
3,711,005,285.06 |
| Held-for-trading Financial Assets |
3,400,328,261.47 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,600,254,859.60 |
| Advances to Suppliers |
344,262,020.02 |
| Other Receivables |
440,460,449.82 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
7,928,515.59 |
| Dividend Receivable |
-- |
| Inventories |
253,901,521.61 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,524,678.86 |
| Other Current Assets |
2,330,897,640.94 |
| Total Current Assets |
12,282,494,993.04 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
17,877,184.73 |
| Long-term Equity Investment |
811,392,443.89 |
| Investment Properties |
-- |
| Fixed Assetes |
13,414,521,801.07 |
| Under-construction Projects |
3,229,488,014.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,293,520,783.72 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
69,787,593.47 |
| Deferred Income Tax Assets |
707,162,112.71 |
| Other Non-Current Assets |
54,748,529.88 |
| Sub-Total of Non-Current Assets |
25,023,337,311.95 |
| Total Assets |
37,305,832,304.99 |
| Short-Term Loans |
2,198,476,527.62 |
| Trading Financial liabilities |
-- |
| Notes Payable |
576,011,934.54 |
| Accounts Payable |
3,954,801,618.15 |
| Accounts Received In Advance |
110,296,005.31 |
| Employee Compensation Payable |
174,336,662.12 |
| Taxes Payable |
350,729,265.41 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,004,220,548.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,916,631,731.73 |
| Other Current Liabilities |
594,272,476.04 |
| Sub-Total of Current Liabilities |
12,440,387,679.41 |
| Long-term Loans |
658,543,909.11 |
| Bonds Payable |
5,768,035,910.87 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
39,882,041.80 |
| Deferred Income Tax Liabilities |
1,956,311.53 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
7,388,306,015.42 |
| Total Liabilities |
19,828,693,694.83 |
| Paid-In Capital(Or Share Stock) |
2,902,263,500.00 |
| Capital Surplus |
2,896,686,268.63 |
| Surplus Reserve |
497,562,701.61 |
| LESS:Treasury Stock |
112,591,448.83 |
| Undistributed Profits |
11,268,020,538.47 |
| Minority Stockholder's Interest |
113,491,263.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
17,363,647,346.31 |
| Owner's Equity（Stockholder's Equity） |
17,477,138,610.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
37,305,832,304.99 |
